The Journal of Urology
Volume 180, Issue 3 , Pages 1146-1153, September 2008

Is Vascular Endothelial Growth Factor Modulation a Predictor of the Therapeutic Efficacy of Gefitinib for Bladder Cancer?

  • Wassim Kassouf

      Affiliations

    • Division of Urology, McGill University Health Center, Montreal, Quebec, Canada
    • ,
  • Gordon A. Brown

      Affiliations

    • Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
    • ,
  • Peter C. Black

      Affiliations

    • Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
    • ,
  • Mark B. Fisher

      Affiliations

    • Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
    • ,
  • Teruo Inamoto

      Affiliations

    • Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
    • ,
  • Tony Luongo

      Affiliations

    • Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
    • ,
  • David Gallagher

      Affiliations

    • Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
    • ,
  • Menashe Bar-Eli

      Affiliations

    • Department of Cancer Biology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
    • ,
  • David J. McConkey

      Affiliations

    • Department of Cancer Biology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
    • ,
  • Liana Adam

      Affiliations

    • Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
    • ,
  • Colin P.N. Dinney

      Affiliations

    • University of Texas M. D. Anderson Cancer Center, Houston, Texas
    • Corresponding Author InformationCorrespondence: Department of Urology, Unit 1373, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030 (telephone: 713-792-3250; FAX: 713-794-4824).
    • Financial interest and/or other relationship with AstraZeneca, GlaxoSmithKline, National Cancer Institute, Canji/Schering-Plough and Abbott/Vysis.

Received 22 December 2007 published online 18 July 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Study received institutional animal care and use committee approval.

 Supported by National Cancer Institute Cancer Center Core Grant CA16672, GU Bladder SPORE CA91846 and a T32 training grant.

PII: S0022-5347(08)01221-4

doi:10.1016/j.juro.2008.05.001

The Journal of Urology
Volume 180, Issue 3 , Pages 1146-1153, September 2008

Article Tools

* Image Usage & Resolution